Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution

Protein aggregation is a key molecular feature underlying a wide array of neurodegenerative disorders, including Alzheimer’s and Parkinson’s diseases. To understand protein aggregation in molecular detail, it is crucial to be able to characterize the array of heterogeneous aggregates that are formed during the aggregation process. We present here a high-throughput method to detect single protein aggregates, in solution, from a label-free aggregation reaction, and we demonstrate the approach with the protein associated with Parkinson’s disease, α-synuclein. The method combines single-molecule confocal microscopy with a range of amyloid-binding extrinsic dyes, including thioflavin T and pentameric formylthiophene acetic acid, and we show that we can observe aggregates at low picomolar concentrations. The detection of individual aggregates allows us to quantify their numbers. Furthermore, we show that this approach also allows us to gain structural insights from the emission intensity of the extrinsic dyes that are bound to aggregates. By analyzing the time evolution of the aggregate populations on a single-molecule level, we then estimate the fragmentation rate of aggregates, a key process that underlies the multiplication of pathological aggregates. We additionally demonstrate that the method permits the detection of these aggregates in biological samples. The capability to detect individual protein aggregates in solution opens up a range of new applications, including exploiting the potential of this method for high-throughput screening of human biofluids for disease diagnosis and early detection.

[1]  M. Leone,et al.  Thioflavin T Promotes Aβ(1-40) Amyloid Fibrils Formation. , 2012, The journal of physical chemistry letters.

[2]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[3]  A. Bonnet,et al.  A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death , 2010, Neurobiology of Aging.

[4]  Alexander K. Buell,et al.  Spatial propagation of protein polymerization. , 2014, Physical review letters.

[5]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[6]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[7]  Mathew H Horrocks,et al.  A mechanistic model of tau amyloid aggregation based on direct observation of oligomers , 2015, Nature Communications.

[8]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[9]  T. Tokuda,et al.  Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease , 2010, Neurology.

[10]  Richard W. Clarke,et al.  Direct characterization of amyloidogenic oligomers by single-molecule fluorescence , 2008, Proceedings of the National Academy of Sciences.

[11]  N. Cairns,et al.  The Structural Basis for Optimal Performance of Oligothiophene-Based Fluorescent Amyloid Ligands: Conformational Flexibility is Essential for Spectral Assignment of a Diversity of Protein Aggregates , 2013, Chemistry.

[12]  K. Blennow,et al.  Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.

[13]  M. Spillantini,et al.  pFTAA: a high affinity oligothiophene probe that detects filamentous tau in vivo and in cultured neurons , 2015, Neural regeneration research.

[14]  P. Kingshott,et al.  Protein aggregation and degradation during iodine labeling and its consequences for protein adsorption to biomaterials. , 2007, Analytical biochemistry.

[15]  Jeffrey H. Kordower,et al.  The role of α-synuclein in Parkinson's disease: insights from animal models , 2003, Nature Reviews Neuroscience.

[16]  C. Dobson,et al.  Fast flow microfluidics and single-molecule fluorescence for the rapid characterization of α-synuclein oligomers. , 2015, Analytical chemistry.

[17]  C. Dobson,et al.  Individual aggregates of amyloid beta induce temporary calcium influx through the cell membrane of neuronal cells , 2016, Scientific Reports.

[18]  V. Uversky,et al.  Analyzing Thioflavin T Binding to Amyloid Fibrils by an Equilibrium Microdialysis-Based Technique , 2012, PloS one.

[19]  Jianmin Gao,et al.  Highly sensitive amyloid detection enabled by thioflavin T dimers. , 2010, Molecular bioSystems.

[20]  Christopher M. Dobson,et al.  Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein , 2012, Cell.

[21]  Christopher M. Dobson,et al.  Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids , 2016, ACS chemical neuroscience.

[22]  V. Uversky,et al.  Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity. , 2008, The journal of physical chemistry. B.

[23]  Hitoshi Takahashi,et al.  The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[24]  Henry Pinkard,et al.  Advanced methods of microscope control using μManager software. , 2014, Journal of biological methods.

[25]  D. Armbruster,et al.  Limit of blank, limit of detection and limit of quantitation. , 2008, The Clinical biochemist. Reviews.

[26]  A. Levey,et al.  Proteomic identification of novel proteins associated with Lewy bodies. , 2008, Frontiers in bioscience : a journal and virtual library.

[27]  S. Nath,et al.  PicoGreen: a better amyloid probe than Thioflavin-T. , 2016, Chemical communications.

[28]  Satoshi Takahashi,et al.  Direct Observation of Aβ Amyloid Fibril Growth and Inhibition , 2004 .

[29]  M. Groenning,et al.  Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status , 2010, Journal of chemical biology.

[30]  Liming Ying,et al.  Ultrasensitive coincidence fluorescence detection of single DNA molecules. , 2003, Analytical chemistry.

[31]  A. Abate,et al.  Observation of spatial propagation of amyloid assembly from single nuclei , 2011, Proceedings of the National Academy of Sciences.

[32]  D. Teplow,et al.  Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer’s disease , 2004, Neurobiology of Aging.

[33]  K. Jacobson,et al.  Single-particle tracking: applications to membrane dynamics. , 1997, Annual review of biophysics and biomolecular structure.

[34]  P. Hof,et al.  Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. , 2009, ACS chemical biology.

[35]  T. S. West Analytical Chemistry , 1969, Nature.

[36]  Tuomas P. J. Knowles,et al.  Kinetic model of the aggregation of alpha-synuclein provides insights into prion-like spreading , 2016, Proceedings of the National Academy of Sciences.

[37]  W. K. Cullen,et al.  Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization , 2008, The Journal of Neuroscience.

[38]  M. Maurin,et al.  REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .